Li‐Yan Khor

668 total citations
13 papers, 532 citations indexed

About

Li‐Yan Khor is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Li‐Yan Khor has authored 13 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Li‐Yan Khor's work include Prostate Cancer Treatment and Research (8 papers), Cancer-related Molecular Pathways (6 papers) and Cell death mechanisms and regulation (3 papers). Li‐Yan Khor is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Cancer-related Molecular Pathways (6 papers) and Cell death mechanisms and regulation (3 papers). Li‐Yan Khor collaborates with scholars based in United States, Canada and France. Li‐Yan Khor's co-authors include Alan Pollack, Howard M. Sandler, M. Elizabeth H. Hammond, David J. Grignon, William U. Shipley, Kyounghwa Bae, Tahseen Al‐Saleem, Gerald E. Hanks, Varagur Venkatesan and Michelle DeSilvio and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Li‐Yan Khor

13 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Li‐Yan Khor United States	13	339	244	173	143	52	13	532
Kazuhiro Daino Japan	15	175 0.5×	267 1.1×	147 0.8×	136 1.0×	235 4.5×	53	575
Atsushi Maeno Japan	14	187 0.6×	178 0.7×	104 0.6×	121 0.8×	25 0.5×	26	430
Ö. Ataman United Kingdom	14	181 0.5×	169 0.7×	313 1.8×	51 0.4×	48 0.9×	23	539
L A Speicher United States	8	295 0.9×	182 0.7×	298 1.7×	104 0.7×	51 1.0×	8	545
Shuiping Gao China	13	99 0.3×	263 1.1×	229 1.3×	194 1.4×	74 1.4×	28	539
Zhiqiang Mo China	10	68 0.2×	246 1.0×	153 0.9×	204 1.4×	29 0.6×	23	466
Yunming Tian China	14	127 0.4×	279 1.1×	198 1.1×	211 1.5×	51 1.0×	24	677
M. Koukourakis Greece	12	125 0.4×	284 1.2×	227 1.3×	125 0.9×	96 1.8×	28	563

Countries citing papers authored by Li‐Yan Khor

Since Specialization

Citations

This map shows the geographic impact of Li‐Yan Khor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Yan Khor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Yan Khor more than expected).

Fields of papers citing papers by Li‐Yan Khor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐Yan Khor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Yan Khor. The network helps show where Li‐Yan Khor may publish in the future.

Co-authorship network of co-authors of Li‐Yan Khor

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Yan Khor. A scholar is included among the top collaborators of Li‐Yan Khor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Yan Khor. Li‐Yan Khor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Khor, Li‐Yan, Hari Prasad Dhakal, Xuefei Jia, et al.. (2016). Tumor Necrosis Adds Prognostically Significant Information to Grade in Clear Cell Renal Cell Carcinoma. The American Journal of Surgical Pathology. 40(9). 1224–1231. 52 indexed citations

Verhoven, Bret, Yan Yan, Mark A. Ritter, et al.. (2013). Ki-67 Is an Independent Predictor of Metastasis and Cause-Specific Mortality for Prostate Cancer Patients Treated on Radiation Therapy Oncology Group (RTOG) 94-08. International Journal of Radiation Oncology*Biology*Physics. 86(2). 317–323. 39 indexed citations

Zhang, Min, John J. Coen, Yoshiyuki Suzuki, et al.. (2010). Survivin Is a Potential Mediator of Prostate Cancer Metastasis. International Journal of Radiation Oncology*Biology*Physics. 78(4). 1095–1103. 46 indexed citations

Pollack, Alan, Kyounghwa Bae, Li‐Yan Khor, et al.. (2009). The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02. Clinical Cancer Research. 15(17). 5478–5484. 24 indexed citations

Khor, Li‐Yan, Kyounghwa Bae, Rebecca Paulus, et al.. (2009). MDM2 and Ki-67 Predict for Distant Metastasis and Mortality in Men Treated With Radiotherapy and Androgen Deprivation for Prostate Cancer: RTOG 92-02. Journal of Clinical Oncology. 27(19). 3177–3184. 75 indexed citations

Zhang, Min, Elizabeth H. Hammond, Yoshiyuki Suzuki, et al.. (2008). Prognostic Value of Survivin in Locally Advanced Prostate Cancer: Study Based on RTOG 8610. International Journal of Radiation Oncology*Biology*Physics. 73(4). 1033–1042. 23 indexed citations

Khor, Li‐Yan, Kyounghwa Bae, Tahseen Al‐Saleem, et al.. (2008). Protein Kinase A RI-α Predicts for Prostate Cancer Outcome: Analysis of Radiation Therapy Oncology Group Trial 86-10. International Journal of Radiation Oncology*Biology*Physics. 71(5). 1309–1315. 27 indexed citations

Stoyanova, Radka, Paul Hachem, Harvey H. Hensley, et al.. (2007). Antisense-MDM2 Sensitizes LNCaP Prostate Cancer Cells to Androgen Deprivation, Radiation, and the Combination In Vivo. International Journal of Radiation Oncology*Biology*Physics. 68(4). 1151–1160. 26 indexed citations

Chakravarti, Arnab, Michelle DeSilvio, Min Zhang, et al.. (2007). Prognostic Value of p16 in Locally Advanced Prostate Cancer: A Study Based on Radiation Therapy Oncology Group Protocol 9202. Journal of Clinical Oncology. 25(21). 3082–3089. 39 indexed citations

10.

Khor, Li‐Yan, Kyounghwa Bae, Alan Pollack, et al.. (2007). COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial. The Lancet Oncology. 8(10). 912–920. 83 indexed citations

11.

Khor, Li‐Yan, Michelle DeSilvio, Rile Li, et al.. (2006). Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10. International Journal of Radiation Oncology*Biology*Physics. 66(1). 25–30. 30 indexed citations

12.

Nguyen, Khanh, Paul Hachem, Li‐Yan Khor, et al.. (2005). Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cells. International Journal of Radiation Oncology*Biology*Physics. 63(1). 238–246. 17 indexed citations

13.

Khor, Li‐Yan, Michelle DeSilvio, Tahseen Al‐Saleem, et al.. (2005). MDM2 as a predictor of prostate carcinoma outcome. Cancer. 104(5). 962–967. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuhiro Daino Breakdown of academic impact, for papers by Atsushi Maeno Breakdown of academic impact, for papers by Ö. Ataman Breakdown of academic impact, for papers by L A Speicher Breakdown of academic impact, for papers by Shuiping Gao Breakdown of academic impact, for papers by Zhiqiang Mo Breakdown of academic impact, for papers by Yunming Tian Breakdown of academic impact, for papers by M. Koukourakis